HoldsUp

Nolan Williams

Stanford Brain Stimulation Lab

Nolan Williams is a neuropsychiatrist and the Director of the Stanford Brain Stimulation Lab. His published research focuses on neuromodulation interventions, including transcranial magnetic stimulation, deep brain stimulation, and Stanford Neuromodulation Therapy (SAINT) for disorders such as treatment-resistant depression and obsessive-compulsive disorder. Additionally, he studies the neural correlates and therapeutic outcomes of magnesium-ibogaine treatments for post-traumatic stress disorder and traumatic brain injury.

32 claims checked on air: 2 context 3 overstated 23 supported 4 unverified

What they said on air - unverified

5 citing their own research

0:25:11unverifiedvery lowOne Dose That Heals Addiction, PTSD, and Brain Injury | The

Ibogaine was placed on France's list of controlled substances in 1966.

"and then placed on the French version of the Controlled Substances Act in '66." (said at 0:25:11)

No published record matching the claim that ibogaine was placed on France's list of controlled substances in 1966 was located; this does not prove the claim false.

0:58:11unverifiedvery lowOne Dose That Heals Addiction, PTSD, and Brain Injury | The

Ibogaine was listed on the French pharmaceutical formulary as a medication for approximately 36 years between the 1930s and 1966.

"why did the French think this was helpful for 36? ... to have a drug on the formulary for 36 years that, you know, wasn't doing anything for the French, it seems unlikely-- it's possible, but unlikely-- that that would have stuck around and been sold for 36 years." (said at 0:58:11)

No published record matching the claim that ibogaine was listed on the French pharmaceutical formulary as a medication for approximately 36 years between the 1930s and 1966 was located; this does not prove the claim false.

1:05:45unverifiedvery lowOne Dose That Heals Addiction, PTSD, and Brain Injury | The

Follow-up data out to one year in special forces veterans treated with ibogaine shows that most participants maintain their clinical improvements.

"So we have data out to a year. It isn't published yet. It's kind of in review now, actually, and uh that looks really good. Uh most people hold it." (said at 1:05:45)

No published record matching one-year follow-up clinical outcome data for ibogaine treatment in Special Operations Forces veterans was located; this does not prove the claim false, as the speaker noted the one-year data was unpublished and under review. Published prospective observational studies in this population have reported significant improvements in functional disability, PTSD, depression, anxiety, and alcohol misuse maintained up to 1 month (Williams et al., Nature Medicine 2024) and 6 months (Davis et al., 2023, 2024) post-treatment.

1:11:59unverifiedvery lowOne Dose That Heals Addiction, PTSD, and Brain Injury | The

As of the time of the discussion, no published studies had administered a standardized personality inventory to assess personality changes following ibogaine administration.

"nobody's done a personality inventory study with ibogaine." (said at 1:11:59)

No published record matching the claim that no studies had administered a standardized personality inventory to assess personality changes following ibogaine administration was located; this does not prove the claim false.

Fact-checked episodes

Publications